Pharmacology · Cytotoxic and Targeted Therapy (Monoclonal Antibodies)

A patient on pembrolizumab develops grade 3 colitis (7 stools/day, severe abdominal pain) despite 2 days of high-dose intravenous methylprednisolone. What is the next recommended step?

  • A Administer infliximab 5 mg/kg as a single dose
  • B Add oral mesalamine and continue steroids
  • C Switch to oral prednisone and taper over 4 weeks
  • D Initiate cyclosporine infusion
Correct answer: A. Administer infliximab 5 mg/kg as a single dose

Explanation

For steroid-refractory immune checkpoint inhibitor colitis, infliximab 5 mg/kg is the standard second-line therapy per ASCO and NCCN guidelines. It is effective in approximately 80% of steroid-refractory cases. Mesalamine has limited evidence. Cyclosporine is reserved for infliximab-refractory cases. Oral steroids are inadequate for grade 3 toxicity.

Reference: DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology, 12th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Cytotoxic and Targeted Therapy (Monoclonal Antibodies) MCQs

See all Cytotoxic and Targeted Therapy (Monoclonal Antibodies) MCQs →